Men's Health

    IGF-1 Levels on Sermorelin: What Your Lab Results Mean

    RespondWell Editorial·Published ·5 min read·growth hormone · IGF-1 · lab testing

    IGF-1 levels on sermorelin are the main lab marker clinicians use to judge whether the peptide is doing its job. Because growth hormone (GH) is released in short pulses and clears quickly, a single GH blood draw says little. IGF-1 (insulin-like growth factor 1) is produced mainly by the liver in response to GH and stays relatively stable through the day, so it serves as a practical proxy for overall GH activity. This guide explains what IGF-1 measures, when to test, how to read your result against the reference range, and what a low or high number may mean.

    What Is IGF-1 and Why Does It Matter on Sermorelin?

    Sermorelin is a growth hormone–releasing hormone (GHRH) analog. It signals the pituitary gland to release its own GH rather than supplying GH directly. That GH then travels to the liver and other tissues, which produce IGF-1. Much of what people associate with GH, including support for lean mass, tissue repair, and fat metabolism, is carried out through IGF-1.

    That chain of events is why IGF-1 is the standard monitoring lab. A rise in IGF-1 after starting sermorelin suggests the pituitary is responding. A flat result suggests something in the chain, whether dosing, timing, adherence, or individual pituitary reserve, needs a closer look. For a deeper look at the signaling pathway, see how sermorelin works.

    When Should You Test IGF-1 on Sermorelin?

    Protocols vary by prescriber, but a common monitoring pattern looks like this:

    • Baseline: before the first dose, so later results have a reference point.
    • First follow-up: often around 6 to 12 weeks after starting, once levels have had time to settle at the current dose.
    • Ongoing: commonly every 3 to 6 months, or after any dose change.

    Because IGF-1 does not swing sharply hour to hour the way GH does, draw timing is less critical than it is for testosterone. Many clinicians still recommend testing at a consistent time, at the same lab, and under similar conditions each time, since different assays can report noticeably different values for the same blood sample.

    What Is a Normal IGF-1 Level?

    There is no single “normal” IGF-1 number. IGF-1 naturally declines with age, so labs report it against an age- and sex-adjusted reference range, and those ranges differ between laboratories and assay methods. A value that is mid-range for a 55-year-old may be low for a 30-year-old.

    Some lab reports also include a Z-score (or standard deviation score), which shows how far your result sits from the average for your age. A Z-score of 0 is the age average; values between roughly −2 and +2 fall inside the reference range. The Z-score is often easier to compare across labs than the raw ng/mL number.

    What IGF-1 Target Do Clinicians Aim For?

    In optimization-focused practice, many clinicians aim for the middle to upper portion of the age-adjusted range while keeping results within it. The goal is a physiologic level, not the highest possible number. Sermorelin’s design supports this: because the body’s IGF-1 and somatostatin feedback loops stay intact, the pituitary tends to self-limit output, which is one reason sermorelin is generally considered less likely to push IGF-1 far above range than direct GH.

    Why Is My IGF-1 Still Low on Sermorelin?

    An IGF-1 result that barely moves is common early on and does not automatically mean the therapy has failed. Factors that clinical experience and research associate with a weaker response include:

    • Eating before the injection. Elevated blood glucose and insulin can blunt GH release, which is why sermorelin is usually taken on an empty stomach, often at bedtime. See sermorelin dosage and timing.
    • Missed or inconsistent doses. Irregular dosing makes the lab result harder to interpret.
    • Reconstitution or storage problems. A peptide that was mixed incorrectly or left unrefrigerated may lose potency.
    • Poor or disrupted sleep. The largest natural GH pulse occurs during deep sleep, so rotating shifts and short sleep can blunt the response.
    • Low calorie or protein intake. Undernutrition lowers IGF-1, which matters for patients in an aggressive calorie deficit, including some on GLP-1 therapy.
    • Other conditions or medications. Hypothyroidism, liver disease, and oral estrogen are known to lower IGF-1.

    Body composition and subjective changes, such as sleep quality and recovery, often appear before or alongside lab changes. The sermorelin results timeline covers what patients typically notice and when.

    Can IGF-1 Get Too High?

    Yes, although it is less common with sermorelin than with direct GH. IGF-1 persistently above the age-adjusted range may be associated with fluid retention, joint aches, tingling or numbness in the hands, and reduced insulin sensitivity. Observational research has also linked chronically high IGF-1 with certain long-term health risks, which is part of why clinicians favor staying within range rather than above it. A result above range usually prompts a dose reduction and repeat testing rather than an abrupt stop, at the prescriber’s discretion.

    Men on testosterone therapy should know that TRT may modestly raise IGF-1 on its own. If you are combining therapies, your clinician may interpret your IGF-1 in that context.

    Frequently Asked Questions About IGF-1 and Sermorelin

    How long does it take for sermorelin to raise IGF-1?

    IGF-1 typically begins rising within the first few weeks of consistent dosing, but most protocols wait about 6 to 12 weeks before the first follow-up lab so the result reflects a stable level at the current dose.

    Do I need to fast before an IGF-1 blood test?

    IGF-1 is relatively stable through the day, so strict fasting is not always required. Some labs and clinicians still prefer a morning, fasting draw for consistency, especially when other labs are drawn at the same time. Follow your lab’s instructions and keep conditions similar between tests.

    Is a GH blood test better than IGF-1 for monitoring sermorelin?

    Generally no. GH is released in brief pulses and can read low or high depending on the exact moment of the draw. IGF-1 reflects average GH activity over time, which makes it the more practical marker for routine monitoring.

    Get Sermorelin With Lab Monitoring Built In

    Sermorelin works best when dosing decisions are guided by real lab data rather than guesswork. RespondWell’s sermorelin program includes clinician oversight and IGF-1 monitoring so your protocol can be adjusted to your results, your schedule, and your goals. Visit the RespondWell store to get started. This article is educational and is not a substitute for individualized medical advice.

    RespondWell

    Healthcare that doesn't suck. Built by first responders, for first responders.

    Verify Approval for www.respondwell.healthColorado Company

    Connect

    ContactText us: (888) 893-8110

    Sign up to receive tips and offers:

    By submitting your email address you agree to receive emails from us. Privacy Policy.

    Ask AI about RespondWell

    © 2026 RespondWell, LLC. All rights reserved. RespondWell, LLC is based in Denver, Colorado, with clinicians and pharmacies licensed in all 50 states.Sitemap

    The information on this website is for general informational purposes only and has not been evaluated by the FDA. It is not a substitute for professional medical advice, diagnosis, or treatment. RespondWell connects first responders with independent licensed providers and pharmacies to improve access to culturally competent care. RespondWell does not practice medicine, prescribe medications, or operate pharmacies — all clinical services are delivered by independent clinicians. Prescriptions require a licensed provider's approval after a medical evaluation; not all patients will qualify. Based on your needs, a provider may prescribe brand-name, generic, or compounded medications. Compounded drugs are not FDA-approved and have not undergone FDA review for safety, effectiveness, or quality. RespondWell does not claim any compounded product is equivalent to, or associated with, any branded or FDA-approved drug. Results vary; no guarantees are made. In a medical emergency, call 911 or go to the nearest ER. Telehealth services and prescriptions may not be available in all states. Safety Information.

    By accessing this website, you agree to our Terms of Use, Privacy Policy, Notice of Privacy Practices, Telehealth Consent, and SMS / Messaging Terms.